Company intelligence / Profile preview

Advanced Bioprocessing

Detroit, Michigan, United States

Ownership: Private
Employees: ~160
Development stage: Other

Overview

Advanced Bioprocessing, a former division of BD (Becton, Dickinson and Company), specialized in manufacturing peptones and cell culture media supplements for biopharmaceutical production, generating approximately $100M in annual revenue with 160 employees. It was acquired by Thermo Fisher Scientific in October 2018 for $477M cash and subsequently integrated into Thermo Fisher's bioproduction portfolio, specifically enhancing their Gibco media offerings. It no longer operates as an independent entity, with key operations located in Hunt Valley, MD, Detroit, Miami, and Singapore.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on Advanced Bioprocessing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Bioprocessing.

Explore the full profile